US Stock MarketDetailed Quotes
PBYI Puma Biotechnology
- 4.950
- -0.120-2.37%
Close May 1 16:00 ET
- 4.930
- -0.020-0.40%
Post 18:11 ET
238.78MMarket Cap11.00P/E (TTM)
5.170High4.900Low256.65KVolume5.050Open5.070Pre Close1.28MTurnover0.87%Turnover Ratio11.00P/E (Static)48.24MShares7.73052wk High4.47P/B145.69MFloat Cap2.13052wk Low--Dividend TTM29.43MShs Float279.370Historical High--Div YieldTTM5.33%Amplitude1.600Historical Low4.979Avg Price1Lot Size
Puma Biotechnology Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 270.65%27.01M | 36.08%10.46M | -38.50%10.62M | 123.76%3.3M | 109.83%2.64M | -176.64%-15.83M | 241.36%7.68M | 64.40%17.26M | -18,648.65%-13.87M | -271.73%-26.9M |
| Net income from continuing operations | 1,079,450.00%21.59M | 318.84%12.27M | 1,710.00%5.8M | -77.31%2.13M | 141.17%1.4M | 100.01%2K | -232.72%-5.61M | 99.19%-360K | 280.00%9.37M | -120.59%-3.4M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | -99.99%1K | --0 | --0 | --0 | --1K |
| Depreciation and amortization | 17.06%11.52M | 17.77%2.89M | 16.48%2.88M | 16.86%2.88M | 17.13%2.88M | -12.96%9.84M | -17.63%2.45M | 1.15%2.47M | -16.15%2.46M | -16.74%2.46M |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | --7M | ---- | ---- | ---- | ---- |
| Change In working capital | 59.88%-17.85M | -720.94%-7.5M | -109.96%-1.23M | 83.92%-4.65M | 84.62%-4.47M | -3,299.24%-44.5M | 107.15%1.21M | -69.43%12.32M | -92.30%-28.93M | -200.66%-29.1M |
| -Change in receivables | -6.95%-8.37M | -56.09%-19.23M | -61.12%2.32M | 90.79%-640K | 67.41%9.19M | -30.77%-7.82M | -41.17%-12.32M | -11.75%5.96M | -104.90%-6.95M | 992.20%5.49M |
| -Change in inventory | -198.88%-2.55M | -251.30%-1.4M | 60.92%1.95M | -711.11%-3.74M | 477.98%635K | 170.67%2.58M | 854.64%926K | 193.00%1.21M | 389.60%612K | 96.08%-168K |
| -Change in prepaid assets | -65.36%820K | 29.51%-559K | -60.87%747K | -168.39%-238K | -3.65%870K | -11.32%2.37M | -934.74%-793K | -17.11%1.91M | 90.16%348K | 926.14%903K |
| -Change in payables and accrued expense | 81.13%-7.13M | 7.76%13.16M | -223.13%-4.29M | 103.48%655K | 51.93%-16.66M | -977.62%-37.8M | 265.51%12.21M | -88.81%3.48M | -64.67%-18.83M | -334.43%-34.66M |
| -Change in other current assets | 176.54%1.52M | -35.99%1.08M | -881.77%-1.42M | 96.61%-124K | 1,176.09%1.98M | -162.05%-1.98M | 41,925.00%1.68M | 570.37%181K | -3,385.71%-3.66M | -105.63%-184K |
| -Change in other current liabilities | -2.06%-940K | 18.80%-203K | -30.34%-232K | -28.91%-272K | 17.38%-233K | 18.78%-921K | 9.09%-250K | 38.62%-178K | 49.64%-211K | -88.00%-282K |
| -Change in other working capital | -29.89%-1.2M | -39.02%-342K | -28.10%-310K | -23.63%-293K | -28.21%-250K | -30.13%-920K | ---246K | ---242K | ---237K | ---195K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 270.65%27.01M | 36.08%10.46M | -38.50%10.62M | 123.76%3.3M | 109.83%2.64M | -176.64%-15.83M | 241.36%7.68M | 64.40%17.26M | -18,648.65%-13.87M | -271.73%-26.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -369.21%-19.13M | 31.19%-8.17M | 39.76%11.18M | -334.50%-4.68M | -294.28%-17.45M | 165.29%7.1M | -356.94%-11.87M | 278.93%8M | 134.85%2M | 269.44%8.98M |
| Net PPE purchase and sale | ---140K | ---45K | ---27K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net intangibles purchase and sale | -78.57%-12.5M | --0 | --0 | --0 | ---12.5M | ---7M | ---7M | --0 | --0 | --0 |
| Net investment purchase and sale | -145.98%-6.49M | -66.74%-8.13M | 40.10%11.21M | -331.10%-4.62M | -155.11%-4.95M | 229.62%14.1M | -205.45%-4.87M | 278.93%8M | 134.85%2M | 269.44%8.98M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -369.21%-19.13M | 31.19%-8.17M | 39.76%11.18M | -334.50%-4.68M | -294.28%-17.45M | 165.29%7.1M | -356.94%-11.87M | 278.93%8M | 134.85%2M | 269.44%8.98M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 0 | 0 | 138.28%12.22M | 121,650.00%2.43M | 99.83%-53K | 0 | 9.85M |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --12.5M | --2.5M | --0 | --0 | --10M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 99.09%-277K | -3,350.00%-69K | ---53K | --0 | ---155K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | --0 | --0 | 138.28%12.22M | 121,650.00%2.43M | 99.83%-53K | --0 | --9.85M |
| Net cash flow | ||||||||||
| Beginning cash position | 4.65%78.79M | 4.77%84.39M | 13.10%62.6M | -4.82%63.99M | 4.65%78.79M | -22.74%75.29M | 5.84%80.55M | -45.74%55.35M | -37.65%67.22M | -22.74%75.29M |
| Current changes in cash | 125.26%7.88M | 229.90%2.29M | -13.53%21.79M | 88.32%-1.39M | -83.53%-14.81M | 115.79%3.5M | -115.56%-1.76M | 197.31%25.2M | -104.60%-11.88M | -177.88%-8.07M |
| End cash Position | 10.01%86.68M | 10.01%86.68M | 4.77%84.39M | 13.10%62.6M | -4.82%63.99M | 4.65%78.79M | 4.65%78.79M | 5.84%80.55M | -45.74%55.35M | -37.65%67.22M |
| Free cash flow | 162.95%14.37M | 1,424.16%10.41M | -38.65%10.59M | 123.27%3.23M | 63.35%-9.86M | -210.54%-22.83M | 112.57%683K | 64.40%17.26M | -18,648.65%-13.87M | -271.73%-26.9M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg